| (Values in U.S. Thousands) | Sep, 2022 | Jun, 2022 | Mar, 2022 | Sep, 2021 | Jun, 2021 |
| Sales | 0 | 0 | 2 | 242 | 222 |
| Sales Growth | unch | -100.00% | -99.21% | +9.15% | +417.56% |
| Net Income | -1,304 | 220 | -2,665 | -4,854 | -22,712 |
| Net Income Growth | -693.79% | +108.24% | +45.09% | +78.63% | -444.16% |
Wesana Health Holdings Inc (WESA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Wesana Health Holdings Inc is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. The Company is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma with the help of extensive clinical research and academic partnerships.